Uploaded November 2014 | Updated September 2026, 31 minutes ago
Most approaches to viral discovery are extremely expensive and available only in sophisticated labs with teams of diagnosticians. Since PREDICT’s lab work takes place in some of the most resource-constrained countries around the globe, a cheaper, more technologically simple alternative was sorely needed.
PREDICT’s diagnostic success lies in the ability of almost any lab to use broadly reactive consensus (genus/family level) PCR, a powerful tool that produces specific, high-resolution data that allows for quicker detection of known and new potential pathogens. PREDICT has developed and optimized detection protocols and capacities in laboratories in 20 countries.
Our approach is especially important for the diagnosis of mystery illnesses in medical hospitals and veterinary labs where testing capacity could be limited, as well as for minimizing spread during outbreak response. By testing targeted samples based on the circumstances that promote disease and the potential route of exposure, we are able to detect known and novel pathogens in tandem, rather than sequentially. This minimizes the spread of viruses that could cause illness, epidemics, and pandemics in people. Those include Ebola, SARS and other potentially deadly viruses.
Most approaches to viral discovery are extremely expensive and available only in sophisticated labs with teams of diagnosticians. Since PREDICT’s lab work takes place in some of the most resource-constrained countries around the globe, a cheaper, more technologically simple alternative was sorely needed.
PREDICT’s diagnostic success lies in the ability of almost any lab to use broadly reactive consensus (genus/family level) PCR, a powerful tool that produces specific, high-resolution data that allows for quicker detection of known and new potential pathogens. PREDICT has developed and optimized detection protocols and capacities in laboratories in 20 countries.
Our approach is especially important for the diagnosis of mystery illnesses in medical hospitals and veterinary labs where testing capacity could be limited, as well as for minimizing spread during outbreak response. By testing targeted samples based on the circumstances that promote disease and the potential route of exposure, we are able to detect known and novel pathogens in tandem, rather than sequentially. This minimizes the spread of viruses that could cause illness, epidemics, and pandemics in people. Those include Ebola, SARS and other potentially deadly viruses.
